Five EU governments are pressing for closer coordination on drug pricing and reimbursement as cost and supply pressures mount
Greece has signalled support for deeper voluntary cooperation between EU countries on medicines procurement, supply security and information-sharing, as a growing number of member states push for a more coordinated European response to mounting affordability and geopolitical pressures.
Speaking to Euractiv ahead of next week’s meeting of EU health ministers, Aris Angelis, Secretary General for Strategic Planning at the Greek Ministry of Health, said closer cooperation could help countries address common challenges while preserving national decision-making powers.
“Ensuring timely and equitable access to medicines, while maintaining resilient and financially sustainable health systems, requires close engagement between the European Union, Member States, and all relevant stakeholders,” Angelis said. “A collaborative approach can help identify common challenges and support effective responses where shared action adds value,” he added.
His comments come as a debate long considered politically sensitive in Brussels is beginning to gain traction: whether Europe should move towards more coordinated approaches to pharmaceutical pricing and procurement.
